Occam Places Allison August as CMO at Comanche Bio
Comanche Biopharma is a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia. Investors include GV, F-Prime, and Population Health Partners. The company has appointed Allison August, M.D. as Chief Medical Officer. Dr. August, an obstetrician-gynecologist, brings more than 25 years of clinical experience to her position at Comanche Biopharma.
August joins Comanche Biopharma from Moderna, where she was Vice President of Clinical Development, Infectious Diseases, and spent over five years in various roles with increasing responsibility for the development of mRNA-based vaccines and the first mRNA-encoded monoclonal antibody.
Before moving to the biopharma industry, August was an academic and private practice obstetrician-gynecologist. Her academic career included faculty positions at the Brown University Medical School and adjunct faculty at Harvard Medical School affiliated hospitals. Dr. August holds a B.A. in the History of Religion from Bryn Mawr College and an M.D. from the University of Chicago
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.